Repay (RPAY) Competitors

$3.43 -0.08 (-2.28%)

Closing price 04:00 PM Eastern

Extended Trading

$3.44 +0.00 (+0.15%)

As of 05:43 PM Eastern

RPAY vs. AHG, NEO, PRSU, RDWR, and LZ

Should you buy Repay stock or one of its competitors? MarketBeat compares Repay with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Repay include Akso Health Group (AHG), NeoGenomics (NEO), Pursuit Attractions and Hospitality (PRSU), Radware (RDWR), and LegalZoom.com (LZ). These companies are all part of the "business services" industry.

How does Repay compare to Akso Health Group?

Repay (NASDAQ:RPAY) and Akso Health Group (NASDAQ:AHG) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.

In the previous week, Repay had 2 more articles in the media than Akso Health Group. MarketBeat recorded 3 mentions for Repay and 1 mentions for Akso Health Group. Repay's average media sentiment score of 0.99 beat Akso Health Group's score of 0.00 indicating that Repay is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Repay	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Akso Health Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Akso Health Group has lower revenue, but higher earnings than Repay.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Repay	$309.26M	1.05	-$256.72M	-$3.06	N/A
Akso Health Group	$14.78M	60.86	-$134.98M	N/A	N/A

Repay has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market. Comparatively, Akso Health Group has a beta of -0.89, meaning that its stock price is 189% less volatile than the broader market.

82.7% of Repay shares are held by institutional investors. Comparatively, 1.2% of Akso Health Group shares are held by institutional investors. 12.0% of Repay shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Repay presently has a consensus target price of $5.54, suggesting a potential upside of 61.39%. Given Repay's stronger consensus rating and higher possible upside, research analysts clearly believe Repay is more favorable than Akso Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Repay	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Akso Health Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Akso Health Group has a net margin of 0.00% compared to Repay's net margin of -82.73%. Repay's return on equity of 10.45% beat Akso Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Repay	-82.73%	10.45%	4.56%
Akso Health Group	N/A	N/A	N/A

Summary

Repay beats Akso Health Group on 11 of the 14 factors compared between the two stocks.

How does Repay compare to NeoGenomics?

NeoGenomics (NASDAQ:NEO) and Repay (NASDAQ:RPAY) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

NeoGenomics currently has a consensus price target of $13.86, suggesting a potential upside of 65.16%. Repay has a consensus price target of $5.54, suggesting a potential upside of 61.39%. Given NeoGenomics' stronger consensus rating and higher possible upside, research analysts clearly believe NeoGenomics is more favorable than Repay.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeoGenomics	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42
Repay	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

NeoGenomics has higher revenue and earnings than Repay. NeoGenomics is trading at a lower price-to-earnings ratio than Repay, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeoGenomics	$727.33M	1.50	-$108.03M	-$0.77	N/A
Repay	$309.26M	1.05	-$256.72M	-$3.06	N/A

In the previous week, NeoGenomics and NeoGenomics both had 3 articles in the media. Repay's average media sentiment score of 0.99 beat NeoGenomics' score of -0.33 indicating that Repay is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeoGenomics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Repay	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NeoGenomics has a beta of 1.81, indicating that its share price is 81% more volatile than the broader market. Comparatively, Repay has a beta of 1.88, indicating that its share price is 88% more volatile than the broader market.

NeoGenomics has a net margin of -13.30% compared to Repay's net margin of -82.73%. Repay's return on equity of 10.45% beat NeoGenomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeoGenomics	-13.30%	-2.80%	-1.72%
Repay	-82.73%	10.45%	4.56%

98.5% of NeoGenomics shares are held by institutional investors. Comparatively, 82.7% of Repay shares are held by institutional investors. 1.1% of NeoGenomics shares are held by insiders. Comparatively, 12.0% of Repay shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

NeoGenomics beats Repay on 9 of the 15 factors compared between the two stocks.

How does Repay compare to Pursuit Attractions and Hospitality?

Repay (NASDAQ:RPAY) and Pursuit Attractions and Hospitality (NYSE:PRSU) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

Repay presently has a consensus target price of $5.54, suggesting a potential upside of 61.39%. Pursuit Attractions and Hospitality has a consensus target price of $34.67, suggesting a potential downside of 19.48%. Given Repay's higher probable upside, analysts clearly believe Repay is more favorable than Pursuit Attractions and Hospitality.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Repay	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Pursuit Attractions and Hospitality	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00

Pursuit Attractions and Hospitality has a net margin of 6.19% compared to Repay's net margin of -82.73%. Repay's return on equity of 10.45% beat Pursuit Attractions and Hospitality's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Repay	-82.73%	10.45%	4.56%
Pursuit Attractions and Hospitality	6.19%	5.30%	3.54%

Repay has a beta of 1.88, indicating that its share price is 88% more volatile than the broader market. Comparatively, Pursuit Attractions and Hospitality has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market.

82.7% of Repay shares are held by institutional investors. Comparatively, 89.9% of Pursuit Attractions and Hospitality shares are held by institutional investors. 12.0% of Repay shares are held by company insiders. Comparatively, 0.8% of Pursuit Attractions and Hospitality shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Pursuit Attractions and Hospitality has higher revenue and earnings than Repay. Repay is trading at a lower price-to-earnings ratio than Pursuit Attractions and Hospitality, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Repay	$309.26M	1.05	-$256.72M	-$3.06	N/A
Pursuit Attractions and Hospitality	$452.42M	2.60	$22.67M	$0.99	43.49

In the previous week, Repay had 2 more articles in the media than Pursuit Attractions and Hospitality. MarketBeat recorded 3 mentions for Repay and 1 mentions for Pursuit Attractions and Hospitality. Repay's average media sentiment score of 0.99 beat Pursuit Attractions and Hospitality's score of 0.91 indicating that Repay is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Repay	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pursuit Attractions and Hospitality	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Pursuit Attractions and Hospitality beats Repay on 9 of the 16 factors compared between the two stocks.

How does Repay compare to Radware?

Repay (NASDAQ:RPAY) and Radware (NASDAQ:RDWR) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, risk, institutional ownership and dividends.

Repay has a beta of 1.88, indicating that its share price is 88% more volatile than the broader market. Comparatively, Radware has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market.

Radware has a net margin of 6.28% compared to Repay's net margin of -82.73%. Repay's return on equity of 10.45% beat Radware's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Repay	-82.73%	10.45%	4.56%
Radware	6.28%	7.69%	4.44%

Radware has lower revenue, but higher earnings than Repay. Repay is trading at a lower price-to-earnings ratio than Radware, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Repay	$309.26M	1.05	-$256.72M	-$3.06	N/A
Radware	$301.85M	3.95	$20.26M	$0.43	65.91

In the previous week, Repay had 2 more articles in the media than Radware. MarketBeat recorded 3 mentions for Repay and 1 mentions for Radware. Repay's average media sentiment score of 0.99 beat Radware's score of 0.71 indicating that Repay is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Repay	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Radware	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

82.7% of Repay shares are held by institutional investors. Comparatively, 73.1% of Radware shares are held by institutional investors. 12.0% of Repay shares are held by company insiders. Comparatively, 21.6% of Radware shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Repay currently has a consensus target price of $5.54, indicating a potential upside of 61.39%. Radware has a consensus target price of $30.00, indicating a potential upside of 5.86%. Given Repay's stronger consensus rating and higher probable upside, equities research analysts plainly believe Repay is more favorable than Radware.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Repay	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Radware	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Repay beats Radware on 10 of the 16 factors compared between the two stocks.

How does Repay compare to LegalZoom.com?

LegalZoom.com (NASDAQ:LZ) and Repay (NASDAQ:RPAY) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment.

LegalZoom.com has higher revenue and earnings than Repay. Repay is trading at a lower price-to-earnings ratio than LegalZoom.com, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LegalZoom.com	$756.04M	1.45	$15.43M	$0.06	106.17
Repay	$309.26M	1.05	-$256.72M	-$3.06	N/A

LegalZoom.com has a beta of 1.33, indicating that its stock price is 33% more volatile than the broader market. Comparatively, Repay has a beta of 1.88, indicating that its stock price is 88% more volatile than the broader market.

LegalZoom.com presently has a consensus price target of $9.25, suggesting a potential upside of 45.21%. Repay has a consensus price target of $5.54, suggesting a potential upside of 61.39%. Given Repay's stronger consensus rating and higher probable upside, analysts clearly believe Repay is more favorable than LegalZoom.com.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LegalZoom.com	3 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Repay	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

LegalZoom.com has a net margin of 1.46% compared to Repay's net margin of -82.73%. LegalZoom.com's return on equity of 11.53% beat Repay's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LegalZoom.com	1.46%	11.53%	3.93%
Repay	-82.73%	10.45%	4.56%

82.0% of LegalZoom.com shares are owned by institutional investors. Comparatively, 82.7% of Repay shares are owned by institutional investors. 5.9% of LegalZoom.com shares are owned by company insiders. Comparatively, 12.0% of Repay shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, LegalZoom.com had 11 more articles in the media than Repay. MarketBeat recorded 14 mentions for LegalZoom.com and 3 mentions for Repay. Repay's average media sentiment score of 0.99 beat LegalZoom.com's score of 0.41 indicating that Repay is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LegalZoom.com	3 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Repay	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

LegalZoom.com beats Repay on 8 of the 15 factors compared between the two stocks.

Get Repay News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RPAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RPAY vs. The Competition

Export

Metric	Repay	Financial Transaction Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$333.31M	$30.20B	$6.49B	$12.23B
Dividend Yield	N/A	3.23%	3.15%	5.27%
P/E Ratio	-1.12	30.98	29.17	25.04
Price / Sales	1.05	10.11	399.47	72.18
Price / Cash	1.77	15.24	22.70	54.25
Price / Book	0.69	6.82	6.75	6.83
Net Income	-$256.72M	$1.10B	$204.94M	$335.69M
7 Day Performance	2.08%	-0.36%	-2.41%	-2.03%
1 Month Performance	-16.55%	-2.12%	-4.81%	-1.90%
1 Year Performance	-16.75%	-12.47%	28.53%	27.36%

Repay Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RPAY Repay	4.0463 of 5 stars	$3.43 -2.3%	$5.54 +61.4%	-14.4%	$333.31M	$309.26M	N/A	580
AHG Akso Health Group	0.0882 of 5 stars	$2.12 +0.2%	N/A	+10.2%	$1.17B	$14.78M	N/A	40	Gap Up
NEO NeoGenomics	2.8623 of 5 stars	$8.75 +1.0%	$13.86 +58.4%	+3.2%	$1.14B	$727.33M	N/A	2,500	Positive News
PRSU Pursuit Attractions and Hospitality	1.8452 of 5 stars	$41.65 +0.1%	$34.67 -16.8%	+43.1%	$1.14B	$452.42M	42.07	2,100
RDWR Radware	1.8333 of 5 stars	$26.79 -2.0%	$30.00 +12.0%	+17.4%	$1.13B	$301.85M	62.30	1,296

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RPAY) was last updated on 5/19/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Repay (RPAY) Competitors

RPAY vs. AHG, NEO, PRSU, RDWR, and LZ

How does Repay compare to Akso Health Group?

Summary

How does Repay compare to NeoGenomics?

Summary

How does Repay compare to Pursuit Attractions and Hospitality?

Summary

How does Repay compare to Radware?

Summary

How does Repay compare to LegalZoom.com?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPAY vs. The Competition

Repay Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Repay (RPAY) Competitors

RPAY vs. AHG, NEO, PRSU, RDWR, and LZ

How does Repay compare to Akso Health Group?

Does the media favor RPAY or AHG?

Which has higher valuation & earnings, RPAY or AHG?

Which has more volatility and risk, RPAY or AHG?

Do insiders and institutionals have more ownership in RPAY or AHG?

Do analysts recommend RPAY or AHG?

Is RPAY or AHG more profitable?

Summary

How does Repay compare to NeoGenomics?

Do analysts prefer NEO or RPAY?

Which has higher earnings & valuation, NEO or RPAY?

Does the media prefer NEO or RPAY?

Which has more risk and volatility, NEO or RPAY?

Is NEO or RPAY more profitable?

Do institutionals & insiders have more ownership in NEO or RPAY?

Summary

How does Repay compare to Pursuit Attractions and Hospitality?

Do analysts prefer RPAY or PRSU?

Is RPAY or PRSU more profitable?

Which has more risk & volatility, RPAY or PRSU?

Do institutionals and insiders have more ownership in RPAY or PRSU?

Which has preferable valuation & earnings, RPAY or PRSU?

Does the media prefer RPAY or PRSU?

Summary

How does Repay compare to Radware?

Which has more risk & volatility, RPAY or RDWR?

Is RPAY or RDWR more profitable?

Which has higher valuation and earnings, RPAY or RDWR?

Does the media favor RPAY or RDWR?

Do institutionals & insiders believe in RPAY or RDWR?

Do analysts recommend RPAY or RDWR?

Summary

How does Repay compare to LegalZoom.com?

Which has stronger valuation and earnings, LZ or RPAY?

Which has more risk and volatility, LZ or RPAY?

Do analysts recommend LZ or RPAY?

Is LZ or RPAY more profitable?

Do institutionals and insiders have more ownership in LZ or RPAY?

Does the media refer more to LZ or RPAY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPAY vs. The Competition

Repay Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools